NCT04261036

Vitamin C for the Prevention of UTI in Women Who Undergo Elective Gynecological Surgeries

Vitamin C for the Prevention of Catheter-associated Urinary Tract Infections in Women Who Undergo Elective Gynecological Surgeries: a Study Protocol for a Randomized Double Blinded Controlled Trial.

• Status: Withdrawn
• Phase: EARLY_Phase 1
• Study type: Interventional
• Enrollment: 0 (actual)
• Sponsor: American University of Beirut Medical Center · Academic / Other
• Sex: Female
• Age: 18 Years – 90 Years
• Healthy volunteers: Not accepted

Summary

This open-label randomized trial aims at assessing the role of Vitamin C pills in the prevention of catheter-associated urinary tract infections in women undergoing elective gynecological surgeries.

Conditions

• Catheter-Associated Urinary Tract Infection, Ascorbic Acid

Interventions

Type	Name	Description
DRUG	Ascorbic Acid 1000 mg	1000 mg ascorbic acid (Vitamin C) for 14 days post-op after an elective gynecological surgery.
OTHER	Placebo	Placebo pills for 14 days post-op after an elective gynecological surgery.

Timeline

• Start date: 2019-07-20
• Primary completion: 2021-07-01
• Completion: 2021-10-01
• First posted: 2020-02-07
• Last updated: 2023-05-30

Locations

1 site across 1 country: Lebanon

Regulatory

• FDA-regulated drug study